Rainmed Medical Ltd. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
No of Months
12
12
12
12
12
12
Profit Before Tax
-125.00
-129.00
-1,571.00
-769.00
-169.00
-54.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
-9.00
-34.00
0.00
-11.00
36.00
-2.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
-90.00
-133.00
-126.00
-91.00
3.00
-23.00
Cash Flow from Investing Activities
5.00
190.00
-602.00
-33.00
8.00
-7.00
Cash Flow from Financing Activities
1.00
-16.00
140.00
767.00
10.00
31.00
Net Cash Inflow / Outflow
-86.00
43.00
-544.00
640.00
23.00
0.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
-2.00
3.00
44.00
-1.00
0.00
0.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in HKD Million
Seasonal companies are compared with the same quarter last year
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Rainmed Medical Ltd.
Figures in Million
consolidated Cash Flow Results
Change(HKD)
Change(%)
Profit Before Tax
-125.011009040756
5003.8569528513
-5,128.00
-102.50%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
-9.71247718115433
320.493044431235
-329.00
-103.03%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
-90.6953244254922
5831.19984089451
-5,921.00
-101.56%
Cash Flow from Investing Activities
5.30185458984647
-685.00289226486
690.00
100.77%
Cash Flow from Financing Activities
1.61440930148904
-4723.95194153667
4,724.00
100.03%
Net Cash Inflow / Outflow
-86.1719425545639
418.24691542123
-504.00
-120.60%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
-2.39288202040719
-3.99809167175034
1.00
40.15%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'24
YoY Growth in year ended Dec 2024 is 32.22% vs -5.40% in Dec 2023
Dec'24
Dec'23
Change(%)
Cash Flow from Operating Activities
-90.70
-133.81
32.22%






